Andrés C. García Montero, Banco Nacional de ADN Carlos III, Universidad de Salamanca.
Monday, July 31.
Biomedical research is not directed towards improving the participants' health.
-
Study subjects.
-
Researchers.
-
Sample repositories (biobanks).
-
Collectors (clinics).
-
Ethics committees.
"Primum non nocere"
To access a biobank a project with scientific quality and ethics is needed.
- Understanding capacity (the information).
- Decision capacity (the consent).
- Conscious: finality, benefits / disadvantages.
- Participation acceptance.
- Revocation right --> there must be a way to cancel an informed consent.
Consent:
- Informed
- Written
- Revokable
Previous information:
-
Finality.
-
Expected benefits.
-
Possible inconveniences.
-
Investigation responsible identity.
-
Analysis location and destination.
-
Right to know the results of the studies.
-
Confidentiality guarantee.
-
Revocation right and effects (the sample is returned, destroyed, anonymized, ...).
-
Health implications.
-
Family implications.
-
Possibility of future contact.
- Informed consent for a research project (only for a specific project).
- Informed consent for a research line (for different projects within a specific area).
- Informed consent for a biobank (for a lot of study types of different projects.
Clinical history access must be always justified.
Idea: Dynamic digital informed consent: the patient can manage his informed consents from a web application and gets alerts to participate in new studies.
- Anonymize (irreversible):
- Advantages:
- Total patient privacy guarantee.
- Absence of risks for the researcher.
- Disadvantages:
- Unable to revoke informed consent.
- Unable to return information.
- Codify (reversible).